Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Guidelines
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
Donate
FAQs
Menu
Topics in Antiviral Medicine
™
Ahead of Issue
Volume 34 Ahead of Issue
Invited Reviews
Selected Highlights From the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs
Kimberly K. Scarsi, PharmD, MS, Catia Marzolini, PharmD, PhD, Fiona Marra, FRPharmS (Consultant), PhD, Alice L. Tseng, PharmD, on behalf of the LiON-PK Group
Weight Gain and Obesity Management in People With HIV: Pathophysiology, Antiretroviral Therapy Effects, and Clinical Strategies
Danna Kashlan, MD, MPH, Zoobia Chaudhry, MBBS
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Guidelines
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
Donate
FAQs
Practice Question of the Week
March 10, 2026: Optimization of Long-Acting Injectable Antiretroviral Therapy
Which of the following approaches is most appropriate when initiating long-acting injectable (LAI) antiretroviral therapy (ART)?
A. Start LAI ART in people with HIV (PWH) with detectable viremia if clinic attendance is expected to be high
B. Initiate LAI ART in PWH who are virologically suppressed on oral ART, who do not have known resistance to regimen components, and who have a plan for missed doses
C. Avoid LAI ART in PWH with prior ART failure, even if currently virologically suppressed
D. Require an oral lead-in for PWH to reduce injection reactions and prevent treatment failure
Register for the Course
View Archived Questions
Leave Feedback
Subscribe
CLOSE
